Early Toxicity and Patient Reported Outcomes from a Radiation Hypofractionation Randomized Trial of Extended vs Accelerated Therapy for Prostate Cancer (HEAT)

There is a strong radiobiologic rationale for utilizing hypo-fractionated radiation to treat prostate cancer (CaP). The application of stereotactic techniques may potentially further extend these clinical benefits to patients and society by decreasing cost, improving access and decreasing patient/caregiver burden by delivering equivalent outcomes in five fractions. The trial is an international randomized trial evaluating accelerated...